Diabetic neurogenic bladder
Conditions
Interventions
Group C:placebo electroacupuncture, Methylcobalamin and Alpha-lipoic acid
Group A:Methylcobalamin and Alpha-lipoic acid
Group B:Electrocupuncture, Methylcobalamin and Alpha-lipoic acid
Sponsors
Hospital of Chengdu University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants meeting all of the following conditions will be included: 1. Aged 18–75 years; male or female; 2. Participants who meet the diagnostic criteria of diabetes mellitus according to the Standards of medical care for type 2 diabetes in China 2019; 3. Participants were detection of bladder post-void residual urine volume (PVR) by transabdominal ultrasound , PVR >= 100 mL; 4. Participants with complaints of urinary system symptoms at first visit to the doctor; 5. Participants who voluntarily agree with the study and willing to sign the informed consent form for the clinical trial.
Exclusion criteria
Exclusion criteria: Participants meeting any one of the following conditions will be excluded: 1. Participants with severe life-threatening primary disease of the cardiovascular, hepatic, renal and hematopoietic system; 2. Participants with severe mental disorder; 3. Participants had spinal cord injury or other nervous system diseases within the past five years and had undergone pelvic, spinal, and urinary bladder surgery; 4. Participants with urinary calculi, infection or tumor within the past 6 months; 5. Participants who received acupuncture treatment within the past 6?months; 6. Pregnant women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 72-hour bladder diary; | — |
Secondary
| Measure | Time frame |
|---|---|
| Urodynamic study;Post-void residual urine volume (PVR);American Urological Association symptom index (AUA-SI); | — |
Countries
China
Contacts
Public ContactChen Qiu
Chengdu University of TCM
Outcome results
None listed